Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.85

-0.76

-0.68

-0.59

Details

Expected EPS

-0.675

Actual EPS

-0.72

Surprise EPS

-0.04

Surprise Percent

+6.67%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.72 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.